SELLAS Life Sciences Group Inc (SLS)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
May 03, 16:00
1.315
-0.02
(-1.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | -0.085M |
| September 30, 2016 | 10.16M |
| June 30, 2016 | 9.907M |
| March 31, 2016 | 9.857M |
| December 31, 2015 | 10.40M |
| September 30, 2015 | -0.925M |
| June 30, 2015 | -3.752M |
| March 31, 2015 | -4.014M |
| December 31, 2014 | -5.528M |
| September 30, 2014 | -8.223M |
| June 30, 2014 | -4.428M |
| March 31, 2014 | -3.985M |
| December 31, 2013 | -12.04M |
| September 30, 2013 | -9.236M |
| June 30, 2013 | -9.956M |
| March 31, 2013 | -10.17M |
| December 31, 2012 | -0.087M |
| September 30, 2012 | -0.188M |
| June 30, 2012 | -0.188M |
| Date | Value |
|---|---|
| March 31, 2012 | 0.054M |
| December 31, 2011 | 0.014M |
| September 30, 2011 | 6.064M |
| June 30, 2011 | 6.059M |
| March 31, 2011 | -0.132M |
| December 31, 2010 | -0.106M |
| September 30, 2010 | -6.055M |
| June 30, 2010 | -6.086M |
| March 31, 2010 | -0.089M |
| December 31, 2009 | -0.083M |
| September 30, 2009 | 8.823M |
| June 30, 2009 | 5.882M |
| March 31, 2009 | -0.17M |
| December 31, 2008 | 9.60M |
| September 30, 2008 | 2.499M |
| June 30, 2008 | -6.335M |
| March 31, 2008 | -0.262M |
| December 31, 2007 | -10.02M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Geron Corp | 32.62M |
| Immuneering Corp | 7.296M |
| Protagonist Therapeutics Inc | -39.26M |
| Akebia Therapeutics Inc | 0.00 |
| Moderna Inc | 2.313B |